Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05323045
Title A First-in-human Dose-escalation and Expansion Study With the Antibody-drug Conjugate BYON3521
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Byondis B.V.
Indications

renal cell carcinoma

clear cell renal cell carcinoma

uveal melanoma

Advanced Solid Tumor

head and neck squamous cell carcinoma

papillary renal cell carcinoma

Therapies

BYON3521

Age Groups: adult | senior
Covered Countries ITA | BEL


No variant requirements are available.